Coutts
4
4M
3
0.01
1
0.25
- Areas of investment
Summary
In 1692 was created Coutts, which is appeared as Corporate Investor.
The overall number of key employees were 18.
The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 1 - 5 millions dollars. The average startup value when the investment from Coutts is 10-50 millions dollars. The high activity for fund was in 2019. Speaking about the real fund results, this Corporate Investor is 47 percentage points more often commits exit comparing to other organizations.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Lightpoint Medical, RevLifter, WOOF & BREW Limited. Among the most popular fund investment industries, there are Subscription Service, Machine Learning. The fund has no exact preference in a number of founders of portfolio startups.
The typical case for the fund is to invest in rounds with 3 participants. Despite the Coutts, startups are often financed by Venture Founders, Seedrs, SBRI Healthcare. The meaningful sponsors for the fund in investment in the same round are Venture Founders, SyndicateRoom, Oxford Technology Management.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 1
- Rounds per year
- 0.01
- Follow on index
- 0.25
- Investments by industry
- Medical Device (2)
- Medical (2)
- Biotechnology (2)
- Affiliate Marketing (1)
- Marketing Automation (1) Show 9 more
- Investments by region
-
- United Kingdom (4)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Avg. valuation at time of investment
- 9M
- Group Appearance index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Lightpoint Medical | 06 Dec 2018 | Biotechnology, Medical Device, Medical | Early Stage Venture | 6M | England, United Kingdom, United Kingdom |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.